TSHA - Taysha Gene Therapies Inc
IEX Last Trade
2.25
0.100 4.444%
Share volume: 1,072,656
Last Updated: Fri 30 Aug 2024 09:59:56 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$2.15
0.10
4.65%
Summary score
20%
Profitability
18%
Dept financing
24%
Liquidity
50%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-461.12%
Return on assets
-18.65%
Return on sales
-592.78%
Return on invested capital
-819.27%
Total debt ratio
74.67%
Debt ratio change over timeo
-0.69%
Current Ratio
3.48%
Quick Ratio
3.48%
Cash Position Ratio
3.26%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
80.93%
Return on assets
-15.43%
Return on sales
-614.35%
Return on invested capital
-3.66%
Total debt ratio
98.01%
Debt ratio change over timeo
-0.35%
Current Ratio
2.37%
Quick Ratio
2.37%
Cash Position Ratio
2.23%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-44.68%
Return on assets
-15.9%
Return on sales
-713.28%
Return on invested capital
148.2%
Total debt ratio
64.8%
Debt ratio change over time
-1.19%
Current Ratio
3.38%
Quick Ratio
3.38%
Cash Position Ratio
3.21%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-700.17%
Return on assets
-101.32%
Return on sales
-501.72%
Return on invested capital
11.21%
Total debt ratio
-69.49%
Debt ratio change over time
-0.69%
Current Ratio
-0.92%
Quick Ratio
-0.92%
Cash Position Ratio
-0.93%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | TSHA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -461.12% | 13.79% | 34.47% | 7.43% |
| Return on assets | -18.65% | 2.76% | 3.15% | 5.62% |
| Return on sales | -592.78% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -819.27% | 2.36% | 5.39% | 19.77% |
| Profitability | 0% | 43% | 66% | 80% |
| Total debt ratio | 74.67% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -0.69% | 308.97% | -6.99% | 1.18% |
| Dept financing | 21% | 50% | 25% | 7% |
| Current Ratio | 2.37% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 2.37% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 2.23% | 0.36% | 1.28% | 2.93% |
| Liquididy | 68% | 13% | 28% | 66% |
| Short-term ratios | TSHA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 80.93% | 13.77% | 13.25% | 3.8% |
| Return on assets | -15.43% | 2.43% | 1.89% | 3.09% |
| Return on sales | -614.35% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -3.66% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 50% | 48% | 76% |
| Total debt ratio | 98.01% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -0.35% | 46.38% | -72.08% | 1.51% |
| Dept financing | 25% | 49% | 24% | 6% |
| Current Ratio | 2.37% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 2.37% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 2.23% | 0.36% | 1.28% | 2.93% |
| Liquididy | 43% | 12% | 31% | 75% |